THERAVECTYS

📍 Paris, France🗓 Founded 2005👥 19 employees💰 Last funded Sep 2010
Biotechnology Research🌐 theravectys.com
Website LinkedIn
Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective transfection mechanism to elicit a potent and targeted immune response previously unseen.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2005
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in THERAVECTYS?
THERAVECTYS has 1 investor on record on gritt.io, 1 mid-stage.
When did THERAVECTYS last raise funding?
The most recent investment in THERAVECTYS recorded on gritt.io was in September 2010.
When was THERAVECTYS founded?
THERAVECTYS was founded in 2005.
What industry is THERAVECTYS in?
THERAVECTYS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is THERAVECTYS based?
THERAVECTYS is headquartered in Paris, France.